相关实验视频
Updated: May 26, 2026

09:45
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
对于Myc驱动的瘤发生,需要一个SUMOylation依赖的转录子程序
Jessica D Kessler1, Kristopher T Kahle, Tingting Sun
1Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
概括
针对SUMO激活酶 (SAE1/2) 导致Myc驱动癌症的合成致死性. 抑制SAE1/2会破坏Mycc的功能.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- Myc 是一个关键的瘤转录因子,在人类癌症中经常受到失调.
- 确定支持Myc瘤计划的途径对于开发向疗法至关重要.
研究的目的:
- 用全基因组RNA干扰屏幕识别与Myc合成致命的基因.
- 研究SUMO激活酶 (SAE1/2) 在Myc驱动癌症中的作用.
主要方法:
- 全基因组RNA干扰屏幕用于识别Myc合成致命基因.
- 不激活SAE2以观察对Myc过度激活的影响.
- 对SUMOylation依赖的Myc切换器 (SMS基因) 的分析及其在线粒状功能中的作用.
- 对小鼠Myc-依赖性瘤生长的SAE2要求的评估.
- 对高Myc的人类乳腺癌的基因表达分析.
主要成果:
- 发现了SUMO激活酶 (SAE1/2) 作为Myc合成致命基因的作用.
- 失去SAE1/2酶活性导致Myc.的合成致死性.
- 在Myc过度激活时,SAE2的失活会导致线粒体灾难和细胞死亡.
- 抑制SAE2将Myc的转录程序从激活切换到抑制.
- 一个依赖于SUMOylation的Myc转换器 (SMS基因) 的子集对于线粒体功能和Myc瘤计划至关重要.
- 在小鼠中,SAE2对于Myc依赖性瘤的生长是必需的.
- 在人类乳腺癌中,低SAE1和SAE2丰度与更长的无转移存活时间相关.
结论:
- 抑制SUMOylation,特别是针对SAE1/2,为Myc驱动的癌症提供了潜在的治疗策略.
- 了解依赖于SUMOylation的Myc开关机制,可以深入了解癌症生物学.
- 向SAE1/2可能是治疗Myc-依赖的人类恶性瘤的一个有希望的途径.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Combinatorial Gene Control
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

